Piper Sandler analyst Sean Wieland downgrades Livongo Health (NASDAQ:LVGO) from Overweight to Neutral and raises the price target from $55 to $143.
Piper Sandler Downgrades Livongo Health to Neutral, Raises Price Target to $143
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.